Traders purchased shares of UnitedHealth Group Incorporated (NYSE:UNH) on weakness during trading on Wednesday. $12.20 million flowed into the stock on the tick-up and $3.64 million flowed out of the stock on the tick-down, for a money net flow of $8.56 million into the stock. Of all stocks tracked, UnitedHealth Group had the 7th highest net in-flow for the day. UnitedHealth Group traded down ($0.86) for the day and closed at $198.46

A number of brokerages have issued reports on UNH. Cantor Fitzgerald restated a “buy” rating and issued a $205.00 price objective on shares of UnitedHealth Group in a research note on Friday, July 7th. Sanford C. Bernstein restated an “outperform” rating and issued a $190.00 price objective on shares of UnitedHealth Group in a research note on Monday, July 10th. Credit Suisse Group restated an “outperform” rating and issued a $200.00 price objective (up previously from $195.00) on shares of UnitedHealth Group in a research note on Thursday, July 13th. Citigroup Inc. upped their price objective on UnitedHealth Group from $195.00 to $213.00 and gave the company a “buy” rating in a research note on Wednesday, July 19th. Finally, Royal Bank Of Canada restated a “buy” rating and issued a $212.00 price objective on shares of UnitedHealth Group in a research note on Thursday, July 20th. One analyst has rated the stock with a hold rating and twenty-five have given a buy rating to the company’s stock. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $203.41.

The stock has a 50 day moving average price of $193.42 and a 200 day moving average price of $178.95. The company has a market cap of $191.81 billion, a price-to-earnings ratio of 23.83 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.38 by $0.08. The company had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. UnitedHealth Group’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same period in the previous year, the business earned $1.96 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Friday, September 8th will be given a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $3.00 annualized dividend and a yield of 1.51%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.13%.

In related news, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction on Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the transaction, the director now directly owns 1,818,898 shares in the company, valued at $348,700,935.58. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the transaction, the director now owns 76,058 shares in the company, valued at $14,753,730.84. The disclosure for this sale can be found here. 0.89% of the stock is currently owned by insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Retirement Systems of Alabama lifted its position in shares of UnitedHealth Group by 2.5% in the first quarter. Retirement Systems of Alabama now owns 640,240 shares of the healthcare conglomerate’s stock valued at $105,006,000 after acquiring an additional 15,403 shares in the last quarter. Honeywell International Inc. purchased a new position in shares of UnitedHealth Group in the first quarter valued at about $35,262,000. Harwood Advisory Group LLC lifted its position in shares of UnitedHealth Group by 0.8% in the first quarter. Harwood Advisory Group LLC now owns 1,885 shares of the healthcare conglomerate’s stock valued at $309,000 after acquiring an additional 15 shares in the last quarter. Mn Services Vermogensbeheer B.V. lifted its position in shares of UnitedHealth Group by 3.9% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 25,730 shares of the healthcare conglomerate’s stock valued at $3,946,000 after acquiring an additional 970 shares in the last quarter. Finally, Suntrust Banks Inc. lifted its position in shares of UnitedHealth Group by 8.5% in the first quarter. Suntrust Banks Inc. now owns 260,811 shares of the healthcare conglomerate’s stock valued at $42,774,000 after acquiring an additional 20,541 shares in the last quarter. Institutional investors own 86.21% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this report on another domain, it was copied illegally and republished in violation of US & international trademark and copyright laws. The legal version of this report can be accessed at https://www.dailypolitical.com/2017/09/06/traders-buy-shares-of-unitedhealth-group-incorporated-unh-on-weakness-2.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.